Knights of Columbus Asset Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-48
Closed -$20.9K 374
2025
Q1
$20.9K Sell
48
-39
-45% -$15.7K ﹤0.01% 343
2024
Q4
$32.1K Sell
87
-22
-20% -$9.21K ﹤0.01% 341
2024
Q3
$56.7K Buy
+109
New +$58.2K ﹤0.01% 347
2020
Q1
Sell
-4,238
Closed -$1.28M 379
2019
Q4
$1.28M Buy
+4,238
New +$1.17M 0.11% 295

Other funds holding ELV

Knights of Columbus Asset Advisors's ELV Position: Q2 2025 in Review

Knights of Columbus Asset Advisors sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 48 shares — an estimated $20.9K sold.

Knights of Columbus Asset Advisors first reported a position in ELV in Q4 2019 and held it in 4 quarters. The position peaked at $1.28M in Q4 2019. 1,590 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Knights of Columbus Asset Advisors reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 48 Elevance Health shares in Q2 2025, an estimated $20.9K.
  • Knights of Columbus Asset Advisors first reported a position in Elevance Health in Q4 2019 and held it in 4 quarters.
  • Knights of Columbus Asset Advisors's Elevance Health position peaked at $1.28M in Q4 2019.
  • 1,590 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2025, filed 22 Jul 2025.